This review attempts to describe the current status of our understanding of the role of TCTP in hypertensive disorders and related diseases, such as atherosclerosis and cataracts, as a consequence of its ability to suppress Na,K-ATPase, and to collate what we have learned from the studies using genetically engineered animal models. This evidence concerns the gene TPT1 and atherosclerosis.